Literature DB >> 28461249

Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APPswe/PS1dE9 transgenic mice: Effect of long-term treatment with paroxetine.

Louise Ørum Olesen1, Mithula Sivasaravanaparan2, Maurizio Severino2, Alicia A Babcock2, Elena V Bouzinova1, Mark J West3, Ove Wiborg1, Bente Finsen4.   

Abstract

Altered neurogenesis may influence hippocampal functions such as learning and memory in Alzheimer's disease. Selective serotonin reuptake inhibitors enhance neurogenesis and have been reported to reduce cerebral amyloidosis in both humans and transgenic mice. We have used stereology to assess the longitudinal changes in the number of doublecortin-expressing neuroblasts and number of granular neurons in the dentate gyrus of APPswe/PS1dE9 transgenic mice. Furthermore, we investigated the effect of long-term paroxetine treatment on the number of neuroblasts and granular neurons, hippocampal amyloidosis, and spontaneous alternation behaviour, a measure of spatial working memory, in transgenic mice. We observed no difference in granular neurons between transgenic and wild type mice up till 18months of age, and no differences with age in wild type mice. The number of neuroblasts and the performance in the spontaneous alternation task was reduced in aged transgenic mice. Paroxetine treatment from 9 to 18months of age reduced hippocampal amyloidosis without affecting the number of neuroblasts or granular neurons. These findings suggest that the amyloidosis affects the differentiation of neuroblasts and spatial working memory, independent of changes in total granular neurons. Furthermore, while long-term paroxetine treatment may be able to reduce hippocampal amyloidosis, it appears to have no effect on total number of granular neurons or spatial working memory.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APP/PS1 mice; Amyloid plaque load; Granule cells; Hippocampus; Neurogenesis; Paroxetine; SSRI; Spontaneous alternation behaviour

Mesh:

Substances:

Year:  2017        PMID: 28461249     DOI: 10.1016/j.nbd.2017.04.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

1.  Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal Subjects.

Authors:  Yvonne Bouter; Caroline Bouter
Journal:  Front Aging Neurosci       Date:  2022-06-23       Impact factor: 5.702

2.  Microglia Express Insulin-Like Growth Factor-1 in the Hippocampus of Aged APPswe/PS1ΔE9 Transgenic Mice.

Authors:  Christa Løth Myhre; Camilla Thygesen; Birgitte Villadsen; Jeanette Vollerup; Laura Ilkjær; Katrine Tækker Krohn; Manuela Grebing; Shuainan Zhao; Asif Manzoor Khan; Lasse Dissing-Olesen; Morten Skovgaard Jensen; Alicia A Babcock; Bente Finsen
Journal:  Front Cell Neurosci       Date:  2019-07-30       Impact factor: 5.505

Review 3.  Adult Hippocampal Neurogenesis in Alzheimer's Disease: An Overview of Human and Animal Studies with Implications for Therapeutic Perspectives Aimed at Memory Recovery.

Authors:  Stefano Farioli-Vecchioli; Valentina Ricci; Silvia Middei
Journal:  Neural Plast       Date:  2022-01-15       Impact factor: 3.599

4.  Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.

Authors:  Christian Ulrich von Linstow; Jonas Waider; Manuela Grebing; Athanasios Metaxas; Klaus Peter Lesch; Bente Finsen
Journal:  Alzheimers Res Ther       Date:  2017-09-12       Impact factor: 6.982

5.  Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer's disease mice.

Authors:  Peng-Hui Ai; Si Chen; Xian-Dong Liu; Xiao-Na Zhu; Yuan-Bo Pan; Dong-Fu Feng; Shengdi Chen; Nan-Jie Xu; Suya Sun
Journal:  Transl Neurodegener       Date:  2020-05-12       Impact factor: 8.014

6.  Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine.

Authors:  Maurizio Severino; Mithula Sivasaravanaparan; Louise Ø Olesen; Christian U von Linstow; Athanasios Metaxas; Elena V Bouzinova; Asif Manzoor Khan; Kate L Lambertsen; Alicia A Babcock; Jan Bert Gramsbergen; Ove Wiborg; Bente Finsen
Journal:  Alzheimers Dement (N Y)       Date:  2018-05-24

7.  Alzheimer's Disease and Its Potential Alternative Therapeutics.

Authors:  Brent Kisby; Juliet T Jarrell; M Enes Agar; David S Cohen; Eric R Rosin; Catherine M Cahill; Jack T Rogers; Xudong Huang
Journal:  J Alzheimers Dis Parkinsonism       Date:  2019-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.